In conclusion, seven hub genes, including FN1, MMP-10, MUC1, KIF23, CDK1, MUC5B, and MUC5AC, might be therapeutic potential biomarkers of NPC. The gene discussed is KIF23; the disease is nasopharyngeal carcinoma.